All studies
Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional
A Study About Fazirsiran in People With and Without Liver Problems.
At a glance
Status
Ongoing, recruiting
Phase
Human Pharmacology (Phase I)- Other
Sponsor
Takeda Development Center Americas Inc.
Enrolment target
41
Start
04 Sep 2023
Who may be eligible?
Age 18 Years to any · Sex: All
Locations (2)
- —Hungary
- —Slovakia
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.